MGC Pharmaceuticals
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - Industrial WA
MGC Pharmaceuticals (ASX: MXC) is EU based specialist medical and cosmetic cannabis company with many years of technical and commercial experience in the medical cannabis industry. The Company’s founders were key figures in the Israeli medical cannabis industry and the core business strategy is to develop and supply high quality non-psychoactive Cannabinoid resin extract (“CBD”) to the growing European cosmetics and medical markets.
The Company listed on the ASX in December 2015, following a reverse takeover of Erin Resources.
The Company listed on the ASX in December 2015, following a reverse takeover of Erin Resources.
Contact Details
1202 Hay Street, WEST PERTH WA 6005
08 6382 3390
Lists and Charts
Public Companies - Industrial WA list sponsored by
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Collapse All Lists and Charts
Article Timeline
Company Activity
| NEW ROLE: Nicole Godresse, Global Chief Sales Officer | 16 Jan 2021 |
| NEWS: Tagged in Research a driver for cannabis | 11 Dec 2020 |
| NEWS: Tagged in Board Moves November 30, 2020 | 30 Nov 2020 |
| NEW ROLE: Narelle Warren, Joint Company Secretary | 30 Nov 2020 |
| NEWS: Tagged in Board Moves September 1, 2020 | 01 Sep 2020 |
| NEW ROLE: Ron Lipsky, Manager, International Relations & Business Development | 01 Sep 2020 |
| NEW ROLE: Nativ Segev, Managing Director | 01 Sep 2020 |
| NEW ROLE: Roby Zomer, President, Chief Technical Officer | 01 Sep 2020 |
| NEW ROLE: Evan Hayes, Non-Executive Director, Strategic Advisor | 01 Sep 2020 |
| REMUNERATION UPDATE: Brett Mitchell, Executive Chair, Co-Founder | 24 Aug 2020 |
